About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Pancreatic Cancer Clinical Trials in Arizona | 290 Studies

Clinical Trials Pancreatic CancerArizona

Pancreatic Cancer Clinical Trials in Arizona

Find 290 clinical trials for pancreatic cancer near Arizona. Connect with research centers in your area.

All Pancreatic Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 201-220 of 290 trials

UnknownProject Survival-Prospective Biomarker DiscoveryThis sample-collection study is open to participants in several categories: healthy volunteers (with or without a family history of pancreatic cancer) and individuals diagnosed…NCT02781012·Gilbert, Arizona and 5 others UnknownSecond-line Study of PEGPH20 and Pembro for HA High Metastatic PDACThis study is the study of the combination of PEGPH20 and Pembrolizumab (MK-3475) for patients with previously treated Hyaluronan High (HA-high) metastatic pancreatic ductal…NCT03634332·Gilbert, Arizona and 4 others

Pancreatic Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid TumorsThis is a Phase 1 dose escalation to assess the safety, tolerability and maximum tolerated dose of subcutaneous administered SDX-7320 in patients with advanced refractory or…NCT02743637·Scottsdale, Arizona and 2 others

RecruitingPROMs After PancreatectomyThe standard of care for a patient with resectable pancreatic is to perform pancreatic resection which, even in the modern era is associated with significant complications and…NCT07173257·Phoenix, Arizona and 1 other

Active not recruitingTesting the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic CancerThis phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer…NCT04340141·Birmingham, Alabama and 452 others

CompletedHedgehog Inhibitors for Metastatic Adenocarcinoma of the PancreasThis is an open-label, single arm, multi-center, Phase II trial to evaluate the progression free survival in patients with metastatic adenocarcinoma of the pancreas treated with a…NCT01088815·Scottsdale, Arizona and 2 others

CompletedDose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLCThe purpose of this study is to evaluate the safety, tolerability, pharmacokinetic (PK), and pharmacodynamic (PD) proﬁles of RMC-4630 and cobimetinib in adult participants with…NCT03989115·Scottsdale, Arizona and 23 others

RecruitingPhase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionThis is a Phase 1, open-label, multicenter, study of the safety, tolerability, PK, PD, and anti-tumor activity of MRTX1719 patients with advanced, unresectable or metastatic solid…NCT05245500·Phoenix, Arizona and 24 others

TerminatedPhase I TH-302 Plus Gemcitabine Plus Nab-Paclitaxel in Pancreatic CancerThis is a multicenter, open-label, Phase 1, dose escalation trial to evaluate the safety, tolerability, and recommended Phase 2 dose (RP2D) of TH-302 in combination with…NCT02047500·Scottsdale, Arizona and 4 others

CompletedA First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051bDS-6051b is an orally administered inhibitor of the tyrosine kinases (ROS1) and neurotropic tyrosine kinase receptors (NTRK).NCT02279433·Scottsdale, Arizona and 5 others

RecruitingCarcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine RegimenA Phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of paltusotine treatment vs placebo as well as the long-term safety of…NCT07087054·Gilbert, Arizona and 72 others

CompletedStudy of CBP501/Cisplatin/Nivolumab Combinations in Advanced Pancreatic CancerMulticenter, randomized, open-label, parallel group phase 2 study to assess the efficacy and tolerance of four combinations of CBP501, cisplatin, and nivolumab administered once…NCT04953962·Tucson, Arizona and 19 others

CompletedStudy of Eryaspase in Combination With Chemotherapy Versus Chemotherapy Alone as 2nd-Line Treatment in PACThis is an open-label, multicenter, randomized, Phase 3 study in patients with ductal adenocarcinoma of the pancreas who have failed only one prior line of systemic anti-cancer…NCT03665441·Scottsdale, Arizona and 15 others

CompletedStudy of MM-398 With or Without 5-FU/LV, Versus 5-FU/LV in Patients With Metastatic Pancreatic CancerThe study is an open label, randomized phase 3 study of MM-398 with or without 5-Fluorouracil (5-FU) and Leucovorin (also known as folinic acid), versus 5-FU and leucovorin in…NCT01494506·Gilbert, Arizona and 78 others

Active not recruitingA Trial to Evaluate Safety and Tolerability of TST001 in Advanced or Metastatic Solid TumorsThis is an open label Phase I/IIa, First in Human trial of TST001, a recombinant humanized anti-Claudin 18.2 (CLDN18.2) IgG1 monoclonal antibody as monotherapy or in combination…NCT04396821·Gilbert, Arizona and 17 others

RecruitingTesting Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerThis phase III trial compares the effect of dose-escalated radiation therapy to usual care in patients with locally advanced unresectable pancreatic ductal adenocarcinoma who have…NCT06958328·Gilbert, Arizona and 332 others

CompletedStudy to Evaluate Efficacy of CO-1.01 as Second Line Therapy for Gemcitabine-Refractory Stage IV Pancreatic AdenocarcinomaThe purpose of this study is to determine whether CO-1.01 is safe and effective for treating metastatic pancreatic cancer that did not respond to gemcitabine.NCT01233375·Tucson, Arizona and 12 others

CompletedFluorouracil, Gemcitabine, and Radiation Therapy in Treating Patients With Cancer of the PancreasRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003216·Birmingham, Alabama and 106 others

CompletedS9700 Combination Chemotherapy in Treating Patients With Stage II or Stage III Pancreatic CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells.NCT00003018·Mobile, Alabama and 83 others

CompletedImmunotherapy Study for Surgically Resected Pancreatic CancerThe purpose of this study is to assess overall survival after treatment with a regimen of adjuvant therapy (Gemcitabine alone or with 5-FU chemoradiation) with or without…NCT01072981·Birmingham, Alabama and 74 others

PreviousPage 11 of 15Next

Other Conditions in Arizona

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia